Diapulse Corp. of America
Diapulse Corp. of America engages in research, development and manufacture of electromedical equipment and accessories. Its offers Diapulse medical technology and Diapulse wound treatment systems, which are indicated for the adjunctive use in the palliative treatment of postoperative edema and pain in superficial soft tissues in acute and chronic wounds. It is a Medicare covered to treat Stage III and IV pressure ulcers, venous stasis ulcers, arterial ulcers, and diabetic ulcers in Hospitals, Nursing Homes, Therapy Clinics and Physician Offices. The company was founded in 1957 and is headquartered in Great Neck, NY.